Structures by: Stepanovs D.
Total: 23
Diltiazem
C22H26N2O4S
CrystEngComm (2016) 18, 7 1235
a=9.3387(2)Å b=13.9027(4)Å c=16.5550(5)Å
α=90.00° β=90.00° γ=90.00°
Dilteazem acetylsalicylate hydrate
C22H27N2O4S,C9H7O4,H2O
CrystEngComm (2016) 18, 7 1235
a=9.9411(4)Å b=10.7606(3)Å c=28.5926(11)Å
α=90.00° β=90.00° γ=90.00°
Diltiazem nicotinate
C22H27N2O4S,C6H4NO2
CrystEngComm (2016) 18, 7 1235
a=8.7897(2)Å b=6.17260(10)Å c=25.1531(7)Å
α=90.00° β=91.5255(11)° γ=90.00°
Diltiazem L-Malate
C26H32N2O9S
CrystEngComm (2016) 18, 7 1235
a=5.89620(10)Å b=9.0320(2)Å c=50.5074(10)Å
α=90.00° β=90.00° γ=90.00°
Propranolol oxalate methanol solvate (2:1:1)
2(C16H22NO2),C2O4,0.9(CH4O)
CrystEngComm (2015) 17, 47 9023
a=10.7741(2)Å b=11.3507(2)Å c=28.2413(6)Å
α=90.00° β=90.00° γ=90.00°
Propranolol maleate (1:1)
C16H22NO2,C4H3O4
CrystEngComm (2015) 17, 47 9023
a=9.2010(3)Å b=8.7153(3)Å c=24.7710(11)Å
α=90.00° β=94.6180(10)° γ=90.00°
Propranolol oxalate (2:1)
C16H22NO2,0.5(C2O4)
CrystEngComm (2015) 17, 47 9023
a=12.9928(6)Å b=6.4517(3)Å c=19.8420(13)Å
α=90.00° β=106.600(2)° γ=90.00°
Propranolol fumarate (2:1)
C16H22NO2,0.5(C4H2O4)
CrystEngComm (2015) 17, 47 9023
a=7.7989(3)Å b=9.1669(4)Å c=12.4724(6)Å
α=89.470(2)° β=75.754(2)° γ=76.412(3)°
Propranolol fumarate (1:1)
C16H22NO2,0.5(C4H4O4),0.5(C4H2O4)
CrystEngComm (2015) 17, 47 9023
a=8.6157(2)Å b=9.9155(2)Å c=13.1345(4)Å
α=97.3910(10)° β=102.2400(10)° γ=109.8990(10)°
C17H22NO4
C17H22NO4
CrystEngComm (2015) 17, 47 9023
a=8.1696(3)Å b=5.6053(2)Å c=18.9321(9)Å
α=90.00° β=98.820(2)° γ=90.00°
(+-)-2-Chloro-<i>N</i>-[(1<i>RS</i>,2<i>RS</i>,4<i>RS</i>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]acetamide
C12H20ClNO
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 10 1117
a=9.6852(2)Å b=10.7589(3)Å c=23.7261(8)Å
α=90.00° β=90.00° γ=90.00°
(+-)-<i>N</i>-[(1<i>RS</i>,2<i>RS</i>,4<i>RS</i>)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-yl]acetamide
C12H21NO
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 10 1117
a=9.6820(6)Å b=10.6540(3)Å c=23.3676(7)Å
α=90.00° β=97.184(10)° γ=90.00°
5-[4-(Diethylamino)phenylmethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C17H21NO4
Acta Crystallographica Section E (2015) 71, 10 1242-1244
a=7.8662(2)Å b=11.4601(3)Å c=18.1517(6)Å
α=90.00° β=96.8580(10)° γ=90.00°
3-<i>O</i>-Benzyl-4(<i>R</i>)-<i>C</i>-(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)-1,2-<i>O</i>-isopropylidene-α-<i>D</i>-erythrofuranose
C23H25N3O4
Acta Crystallographica Section E (2015) 71, 12 1542-1544
a=9.5276(2)Å b=10.0030(2)Å c=21.9495(7)Å
α=90.00° β=90.00° γ=90.00°
3-Amino-5,5-dimethyl-2-[(<i>E</i>)-2-nitroethenyl]cyclohex-2-en-1-one
C10H14N2O3
Acta Crystallographica Section E (2014) 70, 11 379-381
a=11.3545(3)Å b=18.1097(5)Å c=10.4689(3)Å
α=90.00° β=100.119(2)° γ=90.00°
(3a<i>R</i>,5<i>S</i>,6<i>R</i>,6a<i>R</i>)-5-[(<i>R</i>)-2,2-Dimethyl-1,3-\ dioxolan-4-yl]-2,2-dimethyl-6-(nitromethyl)tetrahydrofuro[2,3-<i>d</i>][1,3]\ dioxole
C13H21NO7
Acta Crystallographica Section E (2016) 72, 3 314-317
a=5.5044(2)Å b=12.6144(4)Å c=21.6348(9)Å
α=90° β=90° γ=90°
3-<i>C</i>-(<i>N</i>-Benzyloxycarbonyl)aminomethyl-3-deoxy-1,2:5,6-di-\ <i>O</i>-isopropylidene-α-<i>D</i>-allofuranose
C21H29NO7
Acta Crystallographica Section E (2015) 71, 10 1212-1215
a=9.3235(3)Å b=5.41180(10)Å c=20.4381(7)Å
α=90.00° β=96.7480(10)° γ=90.00°
(furosemide).(pentoxifylline)
C12H11ClN2O5S,C13H18N4O3
Acta Crystallographica Section C (2012) 68, 12 o488-o491
a=8.0948(2)Å b=9.3747(2)Å c=36.2910(10)Å
α=90.00° β=93.1280(10)° γ=90.00°
(furosemide).(pentoxifylline).(acetone)
C13H18N4O3,C12H11ClN2O5S,C3H6O
Acta Crystallographica Section C (2012) 68, 12 o488-o491
a=9.3099(2)Å b=9.5317(3)Å c=19.2653(7)Å
α=99.733(2)° β=96.057(2)° γ=109.197(3)°
(furosemide).(pentoxifylline).(water)
C12H11ClN2O5S,C13H18N4O3,H2O
Acta Crystallographica Section C (2012) 68, 12 o488-o491
a=8.4052(2)Å b=9.4494(3)Å c=19.6748(9)Å
α=92.6490(10)° β=99.170(2)° γ=111.4660(10)°
Pentoxifylline
C13H18N4O3
Acta Crystallographica Section E (2011) 67, 11 o2851
a=9.743(6)Å b=17.410(8)Å c=7.956(3)Å
α=90.00° β=90.89(2)° γ=90.00°
Betulin 3,28-di-O-tosylate
C44H62O6S2
Acta Crystallographica Section E (2014) 70, 8 o879-o880
a=6.98240(10)Å b=18.2035(4)Å c=31.4449(9)Å
α=90.00° β=90.00° γ=90.00°
2,6-Dichloro-9-(2,3',5'-tri-<i>O</i>-acetyl-β-<i>D</i>-ribofuranosyl)-9<i>H</i>-purine
C16H16Cl2N4O7
Acta Crystallographica Section E (2014) 70, 2 o108-o109
a=10.1324(2)Å b=9.6887(3)Å c=10.5399(2)Å
α=90.00° β=106.537(2)° γ=90.00°